HK1039892A1 - 止血和免疫功能的抑制劑 - Google Patents

止血和免疫功能的抑制劑

Info

Publication number
HK1039892A1
HK1039892A1 HK02101086.1A HK02101086A HK1039892A1 HK 1039892 A1 HK1039892 A1 HK 1039892A1 HK 02101086 A HK02101086 A HK 02101086A HK 1039892 A1 HK1039892 A1 HK 1039892A1
Authority
HK
Hong Kong
Prior art keywords
hemostasis
inhibitors
immune function
related protein
complement related
Prior art date
Application number
HK02101086.1A
Other languages
English (en)
Inventor
O Sheppard Paul
W Lasser Gerald
D Bishop Paul
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of HK1039892A1 publication Critical patent/HK1039892A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
HK02101086.1A 1999-02-19 2002-02-15 止血和免疫功能的抑制劑 HK1039892A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25360499A 1999-02-19 1999-02-19
US44479499A 1999-11-22 1999-11-22
PCT/US2000/004161 WO2000048625A2 (en) 1999-02-19 2000-02-17 Inhibitors for use in hemostasis and immune function

Publications (1)

Publication Number Publication Date
HK1039892A1 true HK1039892A1 (zh) 2002-05-17

Family

ID=26943406

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101086.1A HK1039892A1 (zh) 1999-02-19 2002-02-15 止血和免疫功能的抑制劑

Country Status (20)

Country Link
US (1) US6448221B1 (zh)
EP (2) EP1154785B1 (zh)
JP (1) JP2002537270A (zh)
KR (1) KR20010102130A (zh)
CN (1) CN1341027A (zh)
AT (1) ATE245439T1 (zh)
AU (1) AU772103B2 (zh)
BR (1) BR0008298A (zh)
CA (1) CA2361273A1 (zh)
CZ (1) CZ20012916A3 (zh)
DE (1) DE60004015T2 (zh)
DK (1) DK1154785T3 (zh)
ES (1) ES2202061T3 (zh)
HK (1) HK1039892A1 (zh)
HU (1) HUP0105284A3 (zh)
IL (1) IL144460A0 (zh)
NO (1) NO20014012L (zh)
PL (1) PL349924A1 (zh)
PT (1) PT1154785E (zh)
WO (1) WO2000048625A2 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525174B1 (en) 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US20040014650A1 (en) * 2002-07-17 2004-01-22 Sheppard Paul D Methods for enhancing wound repair
US6544946B1 (en) * 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
DE60124285T3 (de) 2000-09-29 2011-03-17 Cordis Corp., Miami Lakes Beschichtete medizinische geräte
CA2478675A1 (en) * 2002-03-08 2003-09-18 Zymogenetics, Inc. Inhibitors for use in hemostasis
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
US9471978B2 (en) 2004-10-04 2016-10-18 Banner Health Methodologies linking patterns from multi-modality datasets
WO2006104964A2 (en) * 2005-03-28 2006-10-05 University Of Louisville Research Foundation, Inc. Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30
WO2007014798A2 (en) * 2005-07-29 2007-02-08 Laboratoires Serono S.A. Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases
WO2008075589A1 (ja) * 2006-12-21 2008-06-26 Chisso Corporation 血小板凝集惹起物質
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
WO2023215294A1 (en) * 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Complement pathway inhibition for wound healing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
EP1000084A4 (en) 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 PROTEIN SEPARATED BY HUMAN
US6265544B1 (en) * 1997-07-18 2001-07-24 Zymogenetics, Inc. Adipocyte-specific protein homologs
PT1000149E (pt) 1997-08-01 2007-08-03 Serono Genetics Inst Sa 5' ests para proteínas segregadas identificadas a partir de tecidos do cérebro.
DE69834334T2 (de) 1997-08-26 2007-04-26 Zymogenetics, Inc., Seattle Für adipozyten spezifische protein homologe
DK1033134T3 (da) 1997-10-29 2007-07-16 Otsuka Pharma Co Ltd Sammensætninger, som inhiberer proliferation af glat muskel, og fremgangsmåde til diagnosticering af arteriosklerose
EP1037979A2 (en) 1997-12-03 2000-09-27 Genentech, Inc. Polypeptides and nucleic acids encoding the same
AU1929599A (en) 1997-12-30 1999-07-19 Chiron Corporation Bone marrow secreted proteins and polynucleotides
ID27813A (id) 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
CA2327317A1 (en) 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
EP1085897A4 (en) 1998-05-21 2003-03-12 Smithkline Beecham Corp ACRP30R1L, ACRP30 APPROVED (PROTEIN ASSOCIATED WITH A 30 KD ADIPOCYTE COMPLEMENT)

Also Published As

Publication number Publication date
CZ20012916A3 (cs) 2002-05-15
WO2000048625A3 (en) 2000-12-28
ES2202061T3 (es) 2004-04-01
EP1154785A2 (en) 2001-11-21
EP1154785B1 (en) 2003-07-23
AU772103B2 (en) 2004-04-08
BR0008298A (pt) 2002-02-19
DE60004015D1 (de) 2003-08-28
PL349924A1 (en) 2002-10-21
HUP0105284A3 (en) 2003-12-29
US6448221B1 (en) 2002-09-10
KR20010102130A (ko) 2001-11-15
AU2883200A (en) 2000-09-04
EP1382345A2 (en) 2004-01-21
ATE245439T1 (de) 2003-08-15
JP2002537270A (ja) 2002-11-05
DE60004015T2 (de) 2004-04-15
CN1341027A (zh) 2002-03-20
IL144460A0 (en) 2002-05-23
HUP0105284A2 (hu) 2002-05-29
NO20014012D0 (no) 2001-08-17
CA2361273A1 (en) 2000-08-24
WO2000048625A2 (en) 2000-08-24
NO20014012L (no) 2001-10-02
DK1154785T3 (da) 2003-11-17
EP1382345A3 (en) 2004-01-28
PT1154785E (pt) 2003-12-31

Similar Documents

Publication Publication Date Title
IL144460A0 (en) Inhibitors for use in hemostasis and immune function
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
WO1992011850A3 (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
WO1994016073A3 (en) Methods and reagents for inhibiting furin endoprotease
BR9406720A (pt) Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
EP1918298A3 (en) Peptide
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
CA2340320A1 (en) Use of an angiogenic factor for the treatment of microascular angiopathies
EP0651655A4 (en) REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
GB9930768D0 (en) Composition
PL354961A1 (en) Prevention and treatment of diseases associated with blood coagulation
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
IL130500A0 (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE50207168D1 (de) Kombinationspräparat zur Therapie von immunologischen Erkrankungen
GEP19991605B (en) Inhibitor, Its Obtaining and Use
DE69626691D1 (de) Komponente b als wundheilendes mittel
EP1714979A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
UA37445A (uk) Протизапальний засіб
RU95112784A (ru) Средство для лечения ран